Report of Foreign Issuer (6-k)
January 18 2018 - 7:07AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
Report
of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16
Under
the Securities Exchange Act of 1934
For
the Month of January 2018
001-36203
(Commission
File Number)
CAN-FITE
BIOPHARMA LTD.
(Exact
name of Registrant as specified in its charter)
10
Bareket Street
KiryatMatalon,
P.O. Box 7537
Petach-Tikva
4951778, Israel
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover
Form 20-F
or Form 40-F.
Form 20-F ☒
Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T
Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T
Rule 101(b)(7): ____
This
Report on Form 6-K (including exhibits thereto) is hereby incorporated by reference into the registrant's Registration Statements
on Form F-3 (File Nos. 333-195124, 333-199033, 333-204795, 333-209037 and 333-220644), to be a part thereof from the date on which
this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.
On January 18, 2018, Can-Fite BioPharma Ltd. (the “Company”) announced that it will hold a Special Meeting of Shareholders
on February 22, 2018 at 4:00 P.M. (Israel time) at the Company’s offices in Petach Tikva, Israel. In connection with the
meeting, the Company furnishes the following documents:
1.
|
A
copy of the Notice and Proxy Statement with respect to the Company’s Special Meeting of Shareholders describing the
proposal to be voted upon at the meeting, the procedure for voting in person or by proxy at the meeting and various other
details related to the meeting, attached hereto as Exhibit 99.1;
|
2.
|
A
form of Proxy Card whereby holders of ordinary shares of the Company may vote at the meeting without attending in person,
attached hereto as Exhibit 99.2; and
|
3.
|
A
form of Voting Instruction Card whereby holders of American Depositary Shares of the Company may vote at the meeting without
attending in person, attached hereto as Exhibit 99.3.
|
Exhibit
Index
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
Can-Fite BioPharma Ltd.
|
|
|
|
Date: January 18, 2018
|
By:
|
/s/
Pnina Fishman
|
|
|
Pnina Fishman
|
|
|
Chief Executive Officer
|
3
Can Fite BioPharma (AMEX:CANF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Can Fite BioPharma (AMEX:CANF)
Historical Stock Chart
From Sep 2023 to Sep 2024